Pharmaceuticals(42)
-
Anti-QSOX1 Antibody for Treating Cancer and Metastasis (No. T4-1642)
Cancer, and especially cancer metastasis, is a leading cause of death worldwide. Research in recent years highlighted the importance of the extracellular matrix (ECM) surrounding the tumor in cancer progression metastasis formation. ... Read more5560 -
Biological Treatment for Pancreatic Cancer (MMP7 mAb) (No. T4-1640)
The innovative concept leading to this high selectivity is immunization with both a synthetic metal-protein mimicry molecule, previously developed by the present inventors, followed by the metalloenzyme itself (e.g. MMP-7). ... Read more5557 -
A TACE Inhibitor (ADAM17) (No. T4-1628)
New generation of superior nature-inspired therapeutics for treating inflammation.Inflammation is characterized by elevated levels of TNF-?. Neutralizing TNF-? ... Read more5551 -
SiRNA Proteasome Inhibitors for Cancer Theraphy (No. T4-1619)
Triple negative breast cancer (TNBC) is an aggressive type of breast cancer, representing over 10% of all breast cancer cases. TNBC is known for its high risk of relapse, poor survival prospects, and near zero survival rates once TNBC metastasizes. ... Read more5548 -
Inhibition of Nuclear Entry of MAPK Cascade Proteins as a Novel Mechanism for Treating Cancer (No. T4-1446)
Peptide sequences for efficient inhibition of nuclear translocation of proteins. ... Read more5473 -
CD84 - a Novel Regulator of B-CLL Survival (No. T4-1441)
Chronic lymphocytic leukemia (CLL), a malignant disease characterized by the accumulation of B lymphocytes in the blood, lymphoid organs, and bone marrow, is the second most common type of leukemia in adults, accounting for about 7,000 new cases of leukemia each year. ... Read more5470 -
Monoclonal Anti-Ubiquitinated Histone H2B Antibody (No. T4-1397)
A novel antibody which can be used, for the first time, to recognize ubiquitinated histone 2B. This technology is novel in its ability to recognize proteins and their destinations, and may serve in diagnostics and immunoprecipitation processes. ... Read more5464 -
On-Chip Synthesis of Biomolecules (No. T4-1369)
Cell-free synthetic platforms that enable complex biological activities such as synthesis and self-assembly of biomolecules, can be employed for various applications, including drug discovery and diagnostics. ... Read more5455 -
A biological drug (PAS- YNS8) for cancer therapy (No. T4-1360)
The human type I interferons number 12 distinct non-allelic alpha proteins, one beta, and one omega, all sharing the same structure and binding the same two cell surface receptors, IFNAR1 and IFNAR2. ... Read more5827
Pages
